AAAAAA

   
Results: 1-20 |
Results: 20
INTERLEUKIN-17 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE
Authors: HENDEL J FEDDERSEN K KIRMAN I NIELSEN OH
Citation: J. Hendel et al., INTERLEUKIN-17 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 114(4), 1998, pp. 4066-4066
ALTERED COLONIC SYNTHESIS OF INTERLEUKIN-13 AND INTERLEUKIN-15 IN ULCERATIVE-COLITIS AND CROHNS-DISEASE
Authors: VAINER B NIELSEN OH HENDEL J HORN T KIRMAN I
Citation: B. Vainer et al., ALTERED COLONIC SYNTHESIS OF INTERLEUKIN-13 AND INTERLEUKIN-15 IN ULCERATIVE-COLITIS AND CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 4511-4511
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
INTERVAL FLUCONAZOLE TREATMENT OF ESOPHAGEAL CANDIDOSIS MONITORED BY A NOVEL NON-ENDOSCOPIC PROCEDURE
Authors: HENDEL J SVEJGAARD E HAGE E HENDEL L
Citation: J. Hendel et al., INTERVAL FLUCONAZOLE TREATMENT OF ESOPHAGEAL CANDIDOSIS MONITORED BY A NOVEL NON-ENDOSCOPIC PROCEDURE, Gastroenterology, 112(4), 1997, pp. 146-146
THE DOSE-RESPONSE RELATIONSHIP IN LANZOPRAZOLE TREATMENT OF GERD - A PH METRIC ENIGMA
Authors: HENDEL L STAVNGAARD T AGGESTRUP S HENDEL J
Citation: L. Hendel et al., THE DOSE-RESPONSE RELATIONSHIP IN LANZOPRAZOLE TREATMENT OF GERD - A PH METRIC ENIGMA, Gastroenterology, 112(4), 1997, pp. 146-146
CYCLOOXYGENASE-2 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE
Authors: HENDEL J NIELSEN OH
Citation: J. Hendel et Oh. Nielsen, CYCLOOXYGENASE-2 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 112(4), 1997, pp. 993-993
EXPRESSION OF CYCLOOXYGENASE-2 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE
Authors: HENDEL J NIELSEN OH
Citation: J. Hendel et Oh. Nielsen, EXPRESSION OF CYCLOOXYGENASE-2 MESSENGER-RNA IN ACTIVE INFLAMMATORY BOWEL-DISEASE, The American journal of gastroenterology, 92(7), 1997, pp. 1170-1173
MONITORING OF OMEPRAZOLE TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE
Authors: HENDEL J HENDEL L HAGE E HENDEL J AGGESTRUP S NIELSEN OH
Citation: J. Hendel et al., MONITORING OF OMEPRAZOLE TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE, European journal of gastroenterology & hepatology, 8(5), 1996, pp. 417-420
UNTITLED
Authors: HENDEL J HENDEL L AGGESTRUP S
Citation: J. Hendel et al., UNTITLED, Alimentary pharmacology & therapeutics, 10(3), 1996, pp. 448-448
SIMPLE FILTER-PAPER TECHNIQUE ALLOWS DETECTION OF MUCOSAL CYTOKINE LEVELS IN-VIVO IN ULCERATIVE-COLITIS - INTERLEUKIN-1 AND INTERLEUKIN-1-RECEPTOR ANTAGONIST
Authors: HENDEL J NIELSEN OH MADSEN S BRYNSKOV J
Citation: J. Hendel et al., SIMPLE FILTER-PAPER TECHNIQUE ALLOWS DETECTION OF MUCOSAL CYTOKINE LEVELS IN-VIVO IN ULCERATIVE-COLITIS - INTERLEUKIN-1 AND INTERLEUKIN-1-RECEPTOR ANTAGONIST, Digestive diseases and sciences, 41(9), 1996, pp. 1775-1779
MORNING OR EVENING DOSAGE OF OMEPRAZOLE FOR GASTROESOPHAGEAL REFLUX DISEASE
Authors: HENDEL J HENDEL L AGGESTRUP S
Citation: J. Hendel et al., MORNING OR EVENING DOSAGE OF OMEPRAZOLE FOR GASTROESOPHAGEAL REFLUX DISEASE, Alimentary pharmacology & therapeutics, 9(6), 1995, pp. 693-697
DILTIAZEM PREVENTS ACCELERATED GRAFT CORONARY-ARTERY DISEASE IN HEART-TRANSPLANT RECIPIENTS
Authors: GHEISSARI A YOKOYAMA T HENDEL J CAPOUYA E FUENTES J
Citation: A. Gheissari et al., DILTIAZEM PREVENTS ACCELERATED GRAFT CORONARY-ARTERY DISEASE IN HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(5), 1995, pp. 2625-2627
EFFECT OF ADVANCED AGE ON SHORT-TERM AND LONG-TERM OUTCOME OF HEART-TRANSPLANTATION
Authors: GHEISSARI A YOKOYAMA T HENDEL J FUENTES J
Citation: A. Gheissari et al., EFFECT OF ADVANCED AGE ON SHORT-TERM AND LONG-TERM OUTCOME OF HEART-TRANSPLANTATION, Transplantation proceedings, 27(5), 1995, pp. 2628-2632
STANDARD DOSAGE SCHEMES OF OMEPRAZOLE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) - AN OBJECTIONABLE PRACTICE
Authors: HENDEL J HENDEL L AGGESTRUP S NIELSEN OH
Citation: J. Hendel et al., STANDARD DOSAGE SCHEMES OF OMEPRAZOLE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) - AN OBJECTIONABLE PRACTICE, Gastroenterology, 108(4), 1995, pp. 112-112
A NOVEL NONINVASIVE TECHNIQUE FOR IN-VIVO MEASUREMENT OF INTESTINAL INTERLEUKIN-1-BETA (IL-1-BETA) AND INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH ULCERATIVE-COLITIS (UC)
Authors: HENDEL J NIELSEN OH BRYNSKOV J
Citation: J. Hendel et al., A NOVEL NONINVASIVE TECHNIQUE FOR IN-VIVO MEASUREMENT OF INTESTINAL INTERLEUKIN-1-BETA (IL-1-BETA) AND INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH ULCERATIVE-COLITIS (UC), Gastroenterology, 108(4), 1995, pp. 833-833
THE OVERALL SAFETY OF TOLFENAMIC ACID
Authors: HENDEL J
Citation: J. Hendel, THE OVERALL SAFETY OF TOLFENAMIC ACID, Pharmacology & toxicology, 75, 1994, pp. 53-55
CIRCULATING SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (SICAM-1) IN ACTIVE INFLAMMATORY BOWEL-DISEASE
Authors: NIELSEN OH LANGHOLZ E HENDEL J BRYNSKOV J
Citation: Oh. Nielsen et al., CIRCULATING SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 (SICAM-1) IN ACTIVE INFLAMMATORY BOWEL-DISEASE, Digestive diseases and sciences, 39(9), 1994, pp. 1918-1923
CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN INFLAMMATORY BOWEL-DISEASE (IBD)
Authors: NIELSEN OH BRYNSKOV J LANGHOLZ E HENDEL J
Citation: Oh. Nielsen et al., CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN INFLAMMATORY BOWEL-DISEASE (IBD), Gastroenterology, 106(4), 1994, pp. 10000744-10000744
MORNING OR EVENING DOSAGE OF OMEPRAZOLE FOR GASTROESOPHAGEAL REFLUX DISEASE
Authors: HENDEL J HENDEL L AGGESTRUP S
Citation: J. Hendel et al., MORNING OR EVENING DOSAGE OF OMEPRAZOLE FOR GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterology, 104(4), 1993, pp. 98-98
THERAPEUTIC MONITORING OF OMEPRAZOLE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
Authors: HENDEL L HAGE E HENDEL J AGGESTRUP S HENDEL J
Citation: L. Hendel et al., THERAPEUTIC MONITORING OF OMEPRAZOLE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterology, 104(4), 1993, pp. 99-99
Risultati: 1-20 |